Teva timeline: CEO says 20-25 manufacturing plants to close in next two years (2024)

FAQs

Is Teva Pharmaceuticals going out of business? ›

TEL AVIV, Feb 20 (Reuters) - Teva Pharmaceutical Industries (TEVA. TA) , opens new tab will remain a single company for generic and branded drugs, and expects to see significant interest in its active pharmaceutical ingredients business that it plans to divest, its head said on Tuesday.

Our global headquarters are based in Israel. Today we have a portfolio of more than 3,600 medicines, and produce approximately 76 billion tablets and capsules a year. We have over 53 manufacturing facilities in more than 33 countries 01.

TEVA Stock 12 Months Forecast

Based on 8 Wall Street analysts offering 12 month price targets for Teva Pharmaceutical in the last 3 months. The average price target is $15.71 with a high forecast of $19.00 and a low forecast of $11.00. The average price target represents a 11.34% change from the last price of $14.11.

Debts from the deal crippled the business, and Actavis's sales of generic opioids in the U.S. made Teva a major target of lawsuits brought by states and local governments over the opioid crisis. Teva is currently finalizing a $4.3 billion settlement of its opioid liabilities.

What happened. Shares of Teva Pharmaceutical Industries (TEVA 2.30%) were sliding 5.4% lower as of 11:47 a.m. ET on Wednesday. The decline came after the drugmaker announced its 2022 full-year and fourth-quarter results. Teva reported fourth-quarter revenue of $3.88 billion, down 5% year over year.

Is Teva Pharmaceutical Industries stock a Buy, Sell or Hold? Teva Pharmaceutical Industries stock has received a consensus rating of buy. The average rating score is WR and is based on 12 buy ratings, 11 hold ratings, and 3 sell ratings.

Mizuho Financial Group, Inc. stock forecast for 2025: $ 3.84 (-1.18%) Mizuho Financial Group, Inc. stock prediction for 2030: $ 3.62 (-6.87%)

Financial Position

The company has a current ratio of 1.02, with a Debt / Equity ratio of 2.68.

New Jersey. US HQ in Parsippany. Manufacturing sites in Fairfield, Elizabeth and a Packaging site in Edison.

Where is Teva's US headquarters? ›

Parsippany-Troy Hills, NJ

Teva Pharmaceuticals USA, Inc. / Headquarters

Parsippany–Troy Hills, commonly known as Parsippany, is a township in Morris County, in the U.S. state of New Jersey.

Wikipedia

As Chief Executive Officer, Richard Francis is leading Teva to a new strategic path for growth by driving great science from the clinic to the patient to provide life-changing medications around the world.

In July 2015, Allergan agreed to sell its generic drug business (Actavis Generics) to Teva for $40.5 billion ($33.75 billion in cash and $6.75 billion worth of shares). As a result, Teva dropped its pursuit of Mylan.

One of the side aspects of the pending Pfizer -Allergan deal, is that Pfizer will end up owning a 10 percent share in Israel-based Teva Pharmaceutical Industries Ltd. In July, Teva acquired Allergan plc's generic drug business for $40.5 billion.

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) and Allergan plc (NYSE: AGN) today announced that Teva has completed its acquisition of Allergan's generics business (“Actavis Generics”).

Berkshire Hathaway, led by Warren Buffett, maintained a position in Teva Pharmaceutical Industries Limited (NYSE: TEVA) since the fourth quarter of 2017. However, in the fourth quarter of 2021, the company sold its entire stake in the pharmaceutical company.

In 1964, Teva partnered with Sintex, a company from Mexico, and Schering Plough. In 1964, Assia and Zori merged and in 1968 acquired a controlling stake in Teva. In 1976, the three companies merged into the modern-day Teva Pharmaceutical Industries Ltd.

Clint Pharmaceuticals, Inc. CVS Pharmacy, Inc. Dakota Drug, Inc. Discount Drug Mart, Inc.